Literature DB >> 20349266

Rapid recurrence of craniopharyngioma following recombinant human growth hormone replacement.

Takafumi Taguchi, Toshihiro Takao, Yasumasa Iwasaki, Kyonghon Pooh, Mizuho Okazaki, Kozo Hashimoto, Yoshio Terada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20349266     DOI: 10.1007/s11060-010-0161-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  6 in total

1.  Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996.

Authors:  D A Price; P Wilton; P Jönsson; K Albertsson-Wikland; P Chatelain; W Cutfield; M B Ranke
Journal:  Horm Res       Date:  1998

2.  Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study experience.

Authors:  S L Blethen; D B Allen; D Graves; G August; T Moshang; R Rosenfeld
Journal:  J Clin Endocrinol Metab       Date:  1996-05       Impact factor: 5.958

3.  Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement.

Authors:  Dau-Ming Niu; Wan-Yuo Guo; Hung-Chi Pan; Tai-Tong Wong
Journal:  Childs Nerv Syst       Date:  2002-03-05       Impact factor: 1.475

4.  Craniopharyngioma: improving outcome by early recognition and treatment of acute complications.

Authors:  B Rajan; S Ashley; D G Thomas; H Marsh; J Britton; M Brada
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-02-01       Impact factor: 7.038

Review 5.  Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up.

Authors:  Hermann L Muller
Journal:  Horm Res       Date:  2008-01-21

6.  Does growth hormone cause relapse of brain tumours?

Authors:  P E Clayton; S M Shalet; H R Gattamaneni; D A Price
Journal:  Lancet       Date:  1987-03-28       Impact factor: 79.321

  6 in total
  4 in total

Review 1.  Pediatric Craniopharyngiomas: A Primer for the Skull Base Surgeon.

Authors:  Christopher Salvatore Graffeo; Avital Perry; Michael J Link; David J Daniels
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-19

2.  Disease control after reduced volume conformal and intensity modulated radiation therapy for childhood craniopharyngioma.

Authors:  Thomas E Merchant; Larry E Kun; Chia-Ho Hua; Shengjie Wu; Xiaoping Xiong; Robert A Sanford; Frederick A Boop
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-12-11       Impact factor: 7.038

3.  Long term sequelae of pediatric craniopharyngioma - literature review and 20 years of experience.

Authors:  Michal Cohen; Sharon Guger; Jill Hamilton
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-28       Impact factor: 5.555

4.  Craniopharyngioma causing bilateral vision loss 4 months after unremarkable magnetic resonance imaging of the brain.

Authors:  Rainy Betts; Curtis E Margo; Mitchell Drucker
Journal:  J Neurosci Rural Pract       Date:  2015 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.